Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Rosiglitazone Enhances Browning Adipocytes in Association with MAPK and PI3-K Pathways During the Differentiation of Telomerase-Transformed Mesenchymal Stromal Cells into Adipocytes.

Fayyad AM, Khan AA, Abdallah SH, Alomran SS, Bajou K, Khattak MNK.

Int J Mol Sci. 2019 Apr 1;20(7). pii: E1618. doi: 10.3390/ijms20071618.

2.

Identification of a novel frameshift mutation in the ILDR1 gene in a UAE family, mutations review and phenotype genotype correlation.

Tlili A, Fahd Al Mutery A, Mahfood M, Kamal Eddine Ahmad Mohamed W, Bajou K.

PLoS One. 2017 Sep 25;12(9):e0185281. doi: 10.1371/journal.pone.0185281. eCollection 2017.

3.

The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis.

Herkenne S, Paques C, Nivelles O, Lion M, Bajou K, Pollenus T, Fontaine M, Carmeliet P, Martial JA, Nguyen NQ, Struman I.

Sci Signal. 2015 Nov 17;8(403):ra117. doi: 10.1126/scisignal.aaa2403. Erratum in: Sci Signal. 2015 Dec 8;8(406):er9.

4.

Corrigendum: PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.

Bajou K, Herkenne S, Thijssen VL, D'Amico S, Nguyen NQ, Bouché A, Tabruyn S, Srahna M, Carabin JY, Nivelles O, Paques C, Cornelissen I, Lion M, Noel A, Gils A, Vinckier S, Declerck PJ, Griffioen AW, Dewerchin M, Martial JA, Carmeliet P, Struman I.

Nat Med. 2015 May;21(5):537. doi: 10.1038/nm0515-537a. No abstract available.

PMID:
25951534
5.

PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.

Bajou K, Herkenne S, Thijssen VL, D'Amico S, Nguyen NQ, Bouché A, Tabruyn S, Srahna M, Carabin JY, Nivelles O, Paques C, Cornelissen I, Lion M, Noel A, Gils A, Vinckier S, Declerck PJ, Griffioen AW, Dewerchin M, Martial JA, Carmeliet P, Struman I.

Nat Med. 2014 Jul;20(7):741-7. doi: 10.1038/nm.3552. Epub 2014 Jun 15. Erratum in: Nat Med. 2015 May;21(5):537. Nat Med. 2014 Oct;20(10):1217.

PMID:
24929950
6.

DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase.

Amand M, Erpicum C, Bajou K, Cerignoli F, Blacher S, Martin M, Dequiedt F, Drion P, Singh P, Zurashvili T, Vandereyken M, Musumeci L, Mustelin T, Moutschen M, Gilles C, Noel A, Rahmouni S.

Mol Cancer. 2014 May 15;13:108. doi: 10.1186/1476-4598-13-108.

7.

Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis.

Bajou K, Peng H, Laug WE, Maillard C, Noel A, Foidart JM, Martial JA, DeClerck YA.

Cancer Cell. 2008 Oct 7;14(4):324-34. doi: 10.1016/j.ccr.2008.08.012.

8.

Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.

Jost M, Maillard C, Lecomte J, Lambert V, Tjwa M, Blaise P, Alvarez Gonzalez ML, Bajou K, Blacher S, Motte P, Humblet C, Defresne MP, Thiry M, Frankenne F, Gothot A, Carmeliet P, Rakic JM, Foidart JM, Noël A.

Am J Pathol. 2007 Oct;171(4):1369-80. Epub 2007 Aug 23.

9.

Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.

Maillard C, Jost M, Rømer MU, Brunner N, Houard X, Lejeune A, Munaut C, Bajou K, Melen L, Dano K, Carmeliet P, Fusenig NE, Foidart JM, Noel A.

Neoplasia. 2005 Jan;7(1):57-66.

10.

Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes.

Masson V, de la Ballina LR, Munaut C, Wielockx B, Jost M, Maillard C, Blacher S, Bajou K, Itoh T, Itohara S, Werb Z, Libert C, Foidart JM, Noël A.

FASEB J. 2005 Feb;19(2):234-6. Epub 2004 Nov 18.

11.

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth.

Bajou K, Maillard C, Jost M, Lijnen RH, Gils A, Declerck P, Carmeliet P, Foidart JM, Noel A.

Oncogene. 2004 Sep 9;23(41):6986-90.

12.

Mouse Aortic Ring Assay: A New Approach of the Molecular Genetics of Angiogenesis.

Masson V VÉ, Devy L, Grignet-Debrus C, Bernt S, Bajou K, Blacher S, Roland G, Chang Y, Fong T, Carmeliet P, Foidart JM, Noël A.

Biol Proced Online. 2002 Oct 28;4:24-31.

13.

Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.

Rakic JM, Lambert V, Munaut C, Bajou K, Peyrollier K, Alvarez-Gonzalez ML, Carmeliet P, Foidart JM, Noël A.

Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1732-9.

14.

The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.

Hajitou A, Grignet C, Devy L, Berndt S, Blacher S, Deroanne CF, Bajou K, Fong T, Chiang Y, Foidart JM, Noël A.

FASEB J. 2002 Nov;16(13):1802-4. Epub 2002 Sep 19.

PMID:
12354694
15.

Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression.

Bajou K, Lewalle JM, Martinez CR, Soria C, Lu H, Noël A, Foidart JM.

Int J Cancer. 2002 Aug 10;100(5):501-6.

16.

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.

Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, Nöel A, Foidart JM.

FASEB J. 2002 Feb;16(2):147-54.

PMID:
11818362

Supplemental Content

Loading ...
Support Center